Neurobiological Technologies (Neurobiological Technologies) Equity-to-Asset : 0.98 (As of Sep. 2009)

Neurobiological Technologies Equity-to-Asset Chart

Neurobiological Technologies Annual Data
	Trend	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09
Equity-to-Asset		Get a 7-Day Free Trial					0.61	-0.51	-2.02	0.47	0.96

Neurobiological Technologies Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
Equity-to-Asset	Get a 7-Day Free Trial															0.44	0.25	0.28	0.96	0.98

Competitive Comparison of Neurobiological Technologies's Equity-to-Asset

For the Biotechnology subindustry, Neurobiological Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurobiological Technologies's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's Equity-to-Asset falls into.

Neurobiological Technologies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Neurobiological Technologies's Equity to Asset Ratio for the fiscal year that ended in Jun. 2009 is calculated as

Neurobiological Technologies's Equity to Asset Ratio for the quarter that ended in Sep. 2009 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies  (OTCPK:NTII) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Neurobiological Technologies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurobiological Technologies (Neurobiological Technologies) Business Description